Skip to main content
ConductScienceScienceDex

Bruckner, Anna Lee

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #2,712
Unclaimed recordClaim profile
  • Translational

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2014 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2023 award categories

  • Pharmacology
  • Pediatrics

NIH Funding · FY2023

Linked Award Amount
$2.4M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#2,712
By linked amount among FY2023 PIs
Earliest Year Loaded
2014
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Bruckner, Anna Lee. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2023 award records by amount

NIH award records listing Bruckner, Anna Lee as a PI. Multi-PI records show the full award amount for context.

  • 5R33AR077495-04R33Contact PI
    JAK Inhibition in Down Syndrome
    University of Colorado · Pharmacology (NIH department code)
    $1.9M
    award amount
  • 1UG3AR082887-01UG3Contact PI
    Study of the Safety, Tolerability, and Efficacy of an iPS Cell-based Therapy for Recessive Dystrophic Epidermolysis Bullosa Delivered with a Spray on Skin Device
    University of Colorado · Pediatrics (NIH department code)
    $538.2K
    award amount

Award organization

Organizations that administered FY2023 awards listing Bruckner, Anna Lee as a PI.

FY2023 award administered by University of Colorado (CO).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2014
    First NIH Award
    University of Colorado
  2. 2017
    $500K Cumulative Funding
  3. 2023
    $1M Cumulative Funding
  4. 2023
    $2M Cumulative Funding
  5. 2023
    Entered Top 50% Nationally
    Ranked #2712
  6. 2023
    Entered Top 25% Nationally
    Ranked #2712

Explore further

Find collaborators for Bruckner, Anna Lee

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →